172 related articles for article (PubMed ID: 7480390)
1. No elevated D2 dopamine receptors in neuroleptic-naive schizophrenic patients revealed by positron emission tomography and [11C]N-methylspiperone.
Nordström AL; Farde L; Eriksson L; Halldin C
Psychiatry Res; 1995 Aug; 61(2):67-83. PubMed ID: 7480390
[TBL] [Abstract][Full Text] [Related]
2. Dopamine D2 receptor density estimates in schizophrenia: a positron emission tomography study with 11C-N-methylspiperone.
Tune LE; Wong DF; Pearlson G; Strauss M; Young T; Shaya EK; Dannals RF; Wilson AA; Ravert HT; Sapp J
Psychiatry Res; 1993 Dec; 49(3):219-37. PubMed ID: 7909948
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of putaminal dopamine D2 receptors in early Parkinson's disease: a comparative PET study with [11C] raclopride and [11C]N-methylspiperone.
Kaasinen V; Ruottinen HM; Någren K; Lehikoinen P; Oikonen V; Rinne JO
J Nucl Med; 2000 Jan; 41(1):65-70. PubMed ID: 10647606
[TBL] [Abstract][Full Text] [Related]
4. D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride.
Farde L; Wiesel FA; Stone-Elander S; Halldin C; Nordström AL; Hall H; Sedvall G
Arch Gen Psychiatry; 1990 Mar; 47(3):213-9. PubMed ID: 1968328
[TBL] [Abstract][Full Text] [Related]
5. MDMA-evoked changes in [11C]raclopride and [11C]NMSP binding in living pig brain.
Rosa-Neto P; Gjedde A; Olsen AK; Jensen SB; Munk OL; Watanabe H; Cumming P
Synapse; 2004 Sep; 53(4):222-33. PubMed ID: 15266554
[TBL] [Abstract][Full Text] [Related]
6. Occupancy of dopamine D(1), D (2) and serotonin (2A) receptors in schizophrenic patients treated with flupentixol in comparison with risperidone and haloperidol.
Reimold M; Solbach C; Noda S; Schaefer JE; Bartels M; Beneke M; Machulla HJ; Bares R; Glaser T; Wormstall H
Psychopharmacology (Berl); 2007 Feb; 190(2):241-9. PubMed ID: 17111172
[TBL] [Abstract][Full Text] [Related]
7. Positron emission tomography of radioligand binding in porcine striatum in vivo: haloperidol inhibition linked to endogenous ligand release.
Ishizu K; Smith DF; Bender D; Danielsen E; Hansen SB; Wong DF; Cumming P; Gjedde A
Synapse; 2000 Oct; 38(1):87-101. PubMed ID: 10941144
[TBL] [Abstract][Full Text] [Related]
8. Positron emission tomography with (18F)methylspiperone demonstrates D2 dopamine receptor binding differences of clozapine and haloperidol.
Karbe H; Wienhard K; Hamacher K; Huber M; Herholz K; Coenen HH; Stöcklin G; Lövenich A; Heiss WD
J Neural Transm Gen Sect; 1991; 86(3):163-73. PubMed ID: 1837996
[TBL] [Abstract][Full Text] [Related]
9. Quantification of neuroreceptors in the living human brain: IV. Effect of aging and elevations of D2-like receptors in schizophrenia and bipolar illness.
Wong DF; Pearlson GD; Tune LE; Young LT; Meltzer CC; Dannals RF; Ravert HT; Reith J; Kuhar MJ; Gjedde A
J Cereb Blood Flow Metab; 1997 Mar; 17(3):331-42. PubMed ID: 9119906
[TBL] [Abstract][Full Text] [Related]
10. N-[11C]methylspiperone PET, in contrast to [11C]raclopride, fails to detect D2 receptor occupancy by an atypical neuroleptic.
Hagberg G; Gefvert O; Bergström M; Wieselgren IM; Lindström L; Wiesel FA; Långström B
Psychiatry Res; 1998 Jun; 82(3):147-60. PubMed ID: 9754439
[TBL] [Abstract][Full Text] [Related]
11. PET measurement of neuroreceptor occupancy by typical and atypical neuroleptics.
Goyer PF; Berridge MS; Morris ED; Semple WE; Compton-Toth BA; Schulz SC; Wong DF; Miraldi F; Meltzer HY
J Nucl Med; 1996 Jul; 37(7):1122-7. PubMed ID: 8965181
[TBL] [Abstract][Full Text] [Related]
12. Test-retest reliability of central [11C]raclopride binding at high D2 receptor occupancy. A PET study in haloperidol-treated patients.
Nyberg S; Farde L; Halldin C
Psychiatry Res; 1996 Oct; 67(3):163-71. PubMed ID: 8912956
[TBL] [Abstract][Full Text] [Related]
13. Striatal D2 dopamine receptor characteristics in neuroleptic-naive schizophrenic patients studied with positron emission tomography.
Hietala J; Syvälahti E; Vuorio K; Någren K; Lehikoinen P; Ruotsalainen U; Räkköläinen V; Lehtinen V; Wegelius U
Arch Gen Psychiatry; 1994 Feb; 51(2):116-23. PubMed ID: 7905257
[TBL] [Abstract][Full Text] [Related]
14. Measuring age-related changes in dopamine D2 receptors with 11C-raclopride and 18F-N-methylspiroperidol.
Volkow ND; Wang GJ; Fowler JS; Logan J; Gatley SJ; MacGregor RR; Schlyer DJ; Hitzemann R; Wolf AP
Psychiatry Res; 1996 May; 67(1):11-6. PubMed ID: 8797238
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the in vitro receptor binding properties of N-[3H]methylspiperone and [3H]raclopride to rat and human brain membranes.
Hall H; Wedel I; Halldin C; Kopp J; Farde L
J Neurochem; 1990 Dec; 55(6):2048-57. PubMed ID: 1977888
[TBL] [Abstract][Full Text] [Related]
16. Comparison of three PET dopamine D2-like receptor ligands, [11C]raclopride, [11C]nemonapride and [11C]N-methylspiperone, in rats.
Ishiwata K; Hayakawa N; Ogi N; Oda K; Toyama H; Endo K; Tanaka A; Senda M
Ann Nucl Med; 1999 Jun; 13(3):161-7. PubMed ID: 10435376
[TBL] [Abstract][Full Text] [Related]
17. Delayed normalization of central D2 dopamine receptor availability after discontinuation of haloperidol decanoate. Preliminary findings.
Nyberg S; Farde L; Halldin C
Arch Gen Psychiatry; 1997 Oct; 54(10):953-8. PubMed ID: 9337776
[TBL] [Abstract][Full Text] [Related]
18. Measurement of striatal and thalamic dopamine D2 receptor binding with 11C-raclopride.
Hirvonen J; Aalto S; Lumme V; Någren K; Kajander J; Vilkman H; Hagelberg N; Oikonen V; Hietala J
Nucl Med Commun; 2003 Dec; 24(12):1207-14. PubMed ID: 14627846
[TBL] [Abstract][Full Text] [Related]
19. Difference in response of D2 receptor binding between 11C-N-methylspiperone and 11C-raclopride against anesthetics in rhesus monkey brain.
Kobayashi K; Inoue O; Watanabe Y; Onoe H; Långström B
J Neural Transm Gen Sect; 1995; 100(2):147-51. PubMed ID: 8962684
[TBL] [Abstract][Full Text] [Related]
20. Suggested minimal effective dose of risperidone based on PET-measured D2 and 5-HT2A receptor occupancy in schizophrenic patients.
Nyberg S; Eriksson B; Oxenstierna G; Halldin C; Farde L
Am J Psychiatry; 1999 Jun; 156(6):869-75. PubMed ID: 10360125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
